Influenza vaccines for avian species.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Topics in Microbiology and Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-3-540-92165-3_6PMID 19768403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccines, Vaccination, and Immunology for Avian Influenza Viruses in Poultry

  2009cited by this paper
• Use of Vaccination in Avian Influenza Control and Eradication

  2008cited by this paper
• Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

  2008cited by this paper
• Efficacy of an Inactivated and a Fowlpox-Vectored Vaccine in Muscovy Ducks Against an Asian H5N1 Highly Pathogenic Avian Influenza Viral Challenge

  2007cited by this paper
• Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.

  2007cited by this paper
• Importance of a Prime–Boost DNA/Protein Vaccination to Protect Chickens Against Low-Pathogenic H7 Avian Influenza Infection

  2007cited by this paper
• Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine.

  2007influential reference
• The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy.

  2007cited by this paper
• Variable effect of vaccination against highly pathogenic avian influenza (H7N7) virus on disease and transmission in pheasants and teals.

  2007cited by this paper
• Mechanistic Bases for Adverse Vaccine Reactions and Vaccine Failures

  2007cited by this paper
• Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine.

  2007cited by this paper
• Lessons Learned from Asian H5N1 Outbreak Control

  2007cited by this paper
• Control and prevention of avian influenza in an evolving scenario.

  2007cited by this paper
• Efficacy of a Fowlpox-Vectored Avian Influenza H5 Vaccine Against Asian H5N1 Highly Pathogenic Avian Influenza Virus Challenge

  2007cited by this paper
• Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

  2007cited by this paper
• Novel Approach to the Development of Effective H5N1 Influenza A Virus Vaccines: Use of M2 Cytoplasmic Tail Mutants

  2007cited by this paper
• Practical Problems in Controlling H5N1 High Pathogenicity Avian Influenza at Village Level in Vietnam and Introduction of Biosecurity Measures

  2007cited by this paper
• Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.

  2007cited by this paper
• Development and Use of Fowlpox Vectored Vaccines for Avian Influenza

  2006cited by this paper
• The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

  2006cited by this paper
• Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.

  2006cited by this paper
• Structure- and oil type-based efficacy of emulsion adjuvants.

  2006cited by this paper
• Principles for Vaccine Protection in Chickens and Domestic Waterfowl against Avian Influenza

  2006cited by this paper
• Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses

  2006cited by this paper
• Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

  2006cited by this paper
• Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza.

  2006cited by this paper
• Amelioration of Influenza Virus Pathogenesis in Chickens Attributed to the Enhanced Interferon-Inducing Capacity of a Virus with a Truncated NS1 Gene

  2006cited by this paper
• Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease.

  2006cited by this paper
• Avian influenza vaccination in North America: strategies and difficulties.

  2006cited by this paper
• Avian influenza virus: prospects for prevention and control by vaccination

  2005cited by this paper
• Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia.

  2005cited by this paper
• Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens.

  2005cited by this paper
• Protection of chickens against challenge with virulent influenza A viruses of Hav5 subtype conferred by prior infection with influenza A viruses of Hsw1 subtype

  2005cited by this paper
• Frequency, Specificity, and Sites of Expansion of CD8+ T Cells during Primary Pulmonary Influenza Virus Infection1

  2005cited by this paper
• Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls

  2005cited by this paper
• Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

  2005cited by this paper
• Vaccine adjuvant technology: from theoretical mechanisms to practical approaches.

  2005cited by this paper
• Field study on the use of inactivated H5N2 vaccine in avian species

  2005cited by this paper
• Highly pathogenic avian influenza (H7N7): vaccination of zoo birds and transmission to non-poultry species.

  2005cited by this paper
• Universal influenza A vaccine: optimization of M2-based constructs.

  2005cited by this paper
• Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus

  2004cited by this paper
• Comparative Susceptibility of Chickens and Turkeys to Avian Influenza A H7N2 Virus Infection and Protective Efficacy of a Commercial Avian Influenza H7N2 Virus Vaccine

  2004cited by this paper
• Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza

  2003cited by this paper
• Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes

  2003cited by this paper
• [Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus].

  2003cited by this paper
• Diseases of poultry.

  2003cited by this paper
• Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3.

  2003cited by this paper
• Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants.

  2003cited by this paper
• Vaccines for List A poultry diseases: emphasis on avian influenza.

  2003cited by this paper
• Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague.

  2003cited by this paper
• Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease

  2003cited by this paper
• Calcium Phosphate Nanoparticles Induce Mucosal Immunity and Protection against Herpes Simplex Virus Type 2

  2002cited by this paper
• Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

  2001cited by this paper
• Adjuvants designed for veterinary and human vaccines.

  2001cited by this paper
• Immunostimulating complexes (ISCOMs) for nasal vaccination.

  2001cited by this paper
• Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene.

  2001cited by this paper
• Cross-Reactive, Cell-Mediated Immunity and Protection of Chickens from Lethal H5N1 Influenza Virus Infection in Hong Kong Poultry Markets

  2001cited by this paper
• Improving vaccine performance with adjuvants.

  2000cited by this paper
• The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model.

  2000cited by this paper
• Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.

  2000influential reference
• Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses.

  2000cited by this paper
• Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.

  2000cited by this paper
• Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.

  1999cited by this paper
• Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines.

  1999cited by this paper
• Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin.

  1999cited by this paper
• Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.

  1998cited by this paper
• Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.

  1998cited by this paper
• Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase.

  1997cited by this paper
• Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.

  1997cited by this paper
• Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils.

  1997cited by this paper
• Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions.

  1996cited by this paper
• Use of DNA Encoding Influenza Hemagglutinin as an Avian Influenza Vaccine

  1993cited by this paper
• Comparison of dimethyl dioctadecyl ammonium bromide, Freund's complete adjuvant and mineral oil for induction of humoral antibodies, cellular immunity and resistance to Newcastle disease virus in chickens.

  1993cited by this paper
• Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

  1993cited by this paper
• Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza.

  1993cited by this paper
• Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant.

  1992cited by this paper
• Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza.

  1992cited by this paper
• Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens.

  1992cited by this paper
• Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens.

  1991cited by this paper
• Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum.

  1991cited by this paper
• Immune response to oil-emulsion vaccines with single or mixed antigens of Newcastle disease, avian influenza, and infectious bronchitis.

  1990cited by this paper
• Efficacy of oil-emulsion vaccines prepared with pigeon paramyxovirus-1, Ulster, and La Sota Newcastle disease viruses.

  1989cited by this paper
• Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin.

  1988influential reference
• Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus.

  1988cited by this paper
• Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections

  1988cited by this paper
• Construction of recombinant fowlpox viruses as vectors for poultry vaccines.

  1988cited by this paper
• Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages.

  1987cited by this paper
• Expression of the murine homeo box gene Hox 1.5 during embryogenesis.

  1987cited by this paper
• The immune response to influenza infection.

  1986cited by this paper
• Efficacy of avian influenza neuraminidase-specific vaccines in chickens.

  1986cited by this paper
• Epizootiology of avian influenza: effect of season on incidence in sentinel ducks and domestic turkeys in Minnesota

  1985cited by this paper
• Turkey influenza vaccination

  1981cited by this paper
• The significance of influenza virus neuraminidase in immunity.

  1974cited by this paper
• A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.

  1973cited by this paper
• A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.

  1973cited by this paper
• Studies with avian influenza A viruses: cross protection experiments in chickens.

  1971cited by this paper
• An Outbreak of Fowl Plague in New Jersey in 1929.

  1934cited by this paper
• Experiments on the Virus of Fowl-Plague. (II)

  1928cited by this paper

• Advances and prospects of mucosal vaccination in the prevention and control of avian influenza.

  2026cites this paper
• Age-related serological response to H9N2 infection in southwest Tripoli, Libya

  2025cites this paper
• MDCK cell line expressing H9N2 avian influenza virus NS1 protein promotes replication of the NS1 gene truncation virus.

  2025cites this paper
• Understanding the pandemic potential of the avian influenza Virus- key insights into pathogenesis, transmission, and host immunity

  2025cites this paper
• Recombinant avian-derived antiviral proteins cIFITM1, cIFITM3, and cViperin as effective adjuvants in inactivated H9N2 subtype avian influenza vaccines.

  2024cites this paper
• Low Pathogenic Avian Influenza: A Permanent Threat to Poultry Farming in Africa

  2023cites this paper
• Determining the Protective Efficacy of Toll-Like Receptor Ligands to Minimize H9N2 Avian Influenza Virus Transmission in Chickens

  2023cites this paper
• Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus

  2023cites this paper
• Mutational antigenic landscape of prevailing H9N2 influenza virus hemagglutinin spectrum.

  2023cites this paper
• Novel technology to develop non-transmissible live influenza virus vaccines through alterations in M2/M42 ion channel expression

  2023cites this paper
• A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals

  2022cites this paper
• Maternal-derived antibodies hinder the antibody response to H9N2 AIV inactivated vaccine in the field

  2022cites this paper
• The time is now: a call to contain H9N2 avian influenza viruses.

  2022cites this paper
• The evolution and future of influenza pandemic preparedness

  2021cites this paper
• Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus

  2021cites this paper
• A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.

  2021cites this paper
• ECOLOGY OF AVIAN VIRUSES

  2021cites this paper
• Combined usage of rHVT-H5 and Re-6 vaccines towards an effective avian influenza vaccination program for commercial layer chickens

  2020cites this paper
• Herbal Medicine Additives as Powerful Agents to Control and Prevent Avian Influenza Virus in Poultry – A Review

  2019cites this paper
• Crude Inactivated Influenza A Virus Adjuvated with a Bispecific Antibody Complex Targeting Chicken CD40 and AIV M2e Confers Protection Against Lethal HPAI Challenge in Chickens

  2018cites this paper
• Urban Chickens as a Pathway for Human Illness? An Examination of Knowledge, Behavior, and Risk

  2018cites this paper
• Of Ducks and Men: Ecology and Evolution of a Zoonotic Pathogen in a Wild Reservoir Host

  2017cites this paper
• Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens

  2017cites this paper
• Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.

  2017cites this paper
• Coadministration of Recombinant Adenovirus Expressing GM-CSF with Inactivated H5N1 Avian Influenza Vaccine Increased the Immune Responses and Protective Efficacy Against a Wild Bird Source of H5N1 Challenge

  2017cites this paper
• Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.

  2017cites this paper
• Modeling the Transmission and Prevention of Infectious Disease

  2017cites this paper
• Current situation of H9N2 subtype avian influenza in China

  2017cites this paper
• Development of universal Influenza vaccine in chicken with insights on the extracellular domain of Matrix protein 2

  2016cites this paper
• Role of vaccination-induced immunity and antigenic distance in the transmission dynamics of highly pathogenic avian influenza H5N1

  2016cites this paper
• Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.

  2016cites this paper
• Comparative Antiviral Efficacy of Zanamivir and Amantadine Against Tunisian Isolate of Avian Influenza Virus ( H 9 N 2 )

  2016cites this paper
• Immunogenicity and protective efficacy of the norovirus P particle-M2e chimeric vaccine in chickens.

  2015cites this paper
• Control of Avian Influenza in Poultry with Antivirals and Molecular Manipulation

  2015cites this paper
• Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection

  2015cites this paper
• Avian Influenza

  2015cites this paper
• NAHEMS Guidelines: Vaccination for Contagious Diseases, Appendix C: Vaccination for High Pathogenicity Avian Influenza

  2015influential citation
• ProtectionPathobiology and Vaccine Isolated from Poultry in an Outbreak in Pathogenic Avian Influenza H7N3 Virus Characterization of the 2012 Highly

  2014cites this paper
• The Socio-Economic Impact of Controlled and Notifiable Wildlife Diseases in the Southern African Development Community (SADC) States of Africa

  2014cites this paper
• NAHEMS Guidelines: Vaccination for Contagious Diseases

  2014cites this paper
• Development of vaccine approaches for pandemic influenza infections

  2014cites this paper
• Characterization of the 2012 Highly Pathogenic Avian Influenza H7N3 Virus Isolated from Poultry in an Outbreak in Mexico: Pathobiology and Vaccine Protection

  2013cites this paper
• Control of influenza in animals

  2013cites this paper
• Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technology.

  2013cites this paper
• Prevention and control of highly pathogenic avian influenza with particular reference to H5N1.

  2013cites this paper
• The emergence and diversification of panzootic H5N1 influenza viruses.

  2013cites this paper
• Transcription factor regulation and cytokine expression following in vitro infection of primary chicken cell culture with low pathogenic avian influenza virus

  2013cites this paper
• Emergence of Influenza Viruses and Crossing the Species Barrier

  2013cites this paper
• Cell culture based production of avian influenza vaccines

  2012cites this paper
• Insight into Alternative Approaches for Control of Avian Influenza in Poultry, with Emphasis on Highly Pathogenic H5N1

  2012cites this paper
• Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector

  2012cites this paper
• Efficacy of rHVT-AI Vector Vaccine in Broilers with Passive Immunity Against Challenge with Two Antigenically Divergent Egyptian Clade 2.2.1 HPAI H5N1 Strains

  2012cites this paper
• Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.

  2011cites this paper
• Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.

  2011cites this paper
• Characterization of the chicken and duck response to H5N1 avian influenza infection

  2011cites this paper
• A difference in heterosubtypic immunity induced by a modified live attenuated avian influenza backbone in mice and ferrets

  2011influential citation
• Pandemic H1N1 Influenza Virus in Chilean Commercial Turkeys with Genetic and Serologic Comparisons to U.S. H1N1 Avian Influenza Vaccine Isolates

  2011cites this paper
• Detection of highly pathogenic avian influenza virus infection in vaccinated chicken flocks by monitoring antibodies against non-structural protein 1 (NS1).

  2011cites this paper
• Antiviral Efficacy of Oseltamivir Against Avian Influenza Virus in Avian Species

  2011cites this paper
• Immunoglobulin genetics and antibody responses to influenza in ducks.

  2011cites this paper
• Species Affected

  2009cites this paper
• The pH of Activation of the Hemagglutinin Protein Regulates H5N1 Influenza Virus Pathogenicity and Transmissibility in Ducks

  2009cites this paper
• Avian Influenza

  2008cites this paper